Clinical effect of bipolar plasmakinetic transurethral resection of prostate in the treatment of high-risk patients with benign prostatic hyperplasia

Objective To explore and analyze the clinical effect and safety of bipolar plasmakinetic transurethral resection of prostate in the treatment of high-risk patients with benign prostatic hyperplasia. Methods Sixty-eight patients of benign prostatic hyperplasia in the Department of Urology in our hospital from December 2010 to December 2012 were treated as the research subjects, which were divided into the control group and the observation group based on the random number table, with 34 cases in each group. Patients in the control group were treated by transurethral resection of prostate for treatment of urinary tract, and those in the observation group were treated by bipolar plasmakinetic transurethral resection of prostate. The two groups were compared in maximal urinary flow rate(Qmax), the rate of complications, International Prostate Symptom Score(IPSS), and quality of life score(QOL). Results In the observation group, the incidence of complications was 26.47%, significantly lower than that in the control group(5.88%), P0.05. Before treatment, the two groups showed no statistically significant difference in IPSS, QOL and Qmax(P0.050, but 2 months later, IPSS, QOL and Qmax were all significantly improved, and the improvements in the observation group was more profound(P0.05). Conclusion Bipolar plasmakinetic transurethral resection of prostate has significant clinical effect for treatment of benign prostatic hyperplasia, with less postoperative complications, improved IPSS, QOL and Qmax, which were significantly better than transurethral resection of pros